Abstract
Verotoxin 1 is an Escherichia coli-derived subunit toxin that specifically binds to the glycolipid globotriosylceramide and is cytotoxic for cells that contain this plasma membrane glycolipid. Glycolipid incorporation experiments have now been performed using human lymphoid cells of the B lineage that lack this receptor, to conclusively demonstrate that globotriosylceramide alone is a functional receptor for this toxin. Globotriosylceramide incorporated into the membrane of toxin-resistant cells provides intracellular access to verotoxin by receptor-mediated endocytosis. Protein synthesis is then inhibited and globotriosylceramide-containing cells are killed.
MeSH Terms
Bacterial Toxins/metabolism,pharmacology
Cell Line
Cell Survival/drug effects
Escherichia coli
Humans
Kinetics
Liposomes
Macromolecular Substances
Methionine/metabolism
Protein Biosynthesis
Receptors, Cell Surface
Receptors, Immunologic/genetics,metabolism
Shiga Toxin 1
Trihexosylceramides/metabolism
Chemicals
Bacterial Toxins
Liposomes
Macromolecular Substances
Receptors, Cell Surface
Receptors, Immunologic
Shiga Toxin 1
Trihexosylceramides
shigella toxin receptor
globotriaosylceramide
Methionine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Waddell T
Department of Microbiology, Hospital for Sick Children, Toronto, Ontario, Canada.
Cohen A
Lingwood C A
References (30)
30 references, click to expand
-
Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.
Infect Immun. 1986 Jul;53(1):135-40
PMID: 3522426
-
Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide.
J Exp Med. 1986 Jun 1;163(6):1391-404
PMID: 3519828
-
Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.
J Biol Chem. 1987 Feb 5;262(4):1779-85
PMID: 3543013
-
Sulfatide-binding proteins.
Chem Phys Lipids. 1986 Dec 15;42(1-3):173-83
PMID: 3549017
-
Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.
J Biol Chem. 1987 Jun 25;262(18):8834-9
PMID: 3298243
-
Pathogenesis of haemolytic uraemic syndrome.
Lancet. 1987 Sep 19;2(8560):687
PMID: 2887970
-
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor.
J Biol Chem. 1987 Dec 15;262(35):17088-91
PMID: 2824515
-
Unravelling HUS.
Lancet. 1987 Dec 19;2(8573):1437-9
PMID: 2891997
-
Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.
Eur J Biochem. 1988 Jan 15;171(1-2):45-50
PMID: 3276522
-
Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
Biochem Biophys Res Commun. 1988 Apr 29;152(2):674-9
PMID: 3284526
-
Direct cytotoxic action of Shiga toxin on human vascular endothelial cells.
Infect Immun. 1988 Sep;56(9):2373-8
PMID: 3044997
-
Sulfogalactolipid binding protein SLIP 1: a conserved function for a conserved protein.
J Cell Physiol. 1988 Dec;137(3):462-8
PMID: 3192627
-
Verotoxin receptor glycolipid in human renal tissue.
Nephron. 1989;51(2):207-10
PMID: 2644572
-
Simultaneous fractionation of four placental neutral glycosphingolipids with a continuous gradient.
J Lipid Res. 1989 Jan;30(1):121-7
PMID: 2918246
-
Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
J Cell Biol. 1989 Apr;108(4):1331-43
PMID: 2564398
-
Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases.
J Infect Dis. 1989 Apr;159(4):774-7
PMID: 2647865
-
Properties and heterogeneity of human fetal pre-B cells transformed by EBV.
J Immunol. 1989 Oct 15;143(8):2470-9
PMID: 2551960
-
Expression of glycolipid receptors to Shiga-like toxin on human B lymphocytes: a mechanism for the failure of long-lived antibody response to dysenteric disease.
Int Immunol. 1990;2(1):1-8
PMID: 1965141
-
Mechanism of activation of adenylate cyclase by Vibrio cholerae enterotoxin.
J Membr Biol. 1975 Jun 3;22(1):29-52
PMID: 805248
-
Directed lipid flow in cell membranes.
Nature. 1976 Mar 4;260(5546):21-3
PMID: 1264188
-
Functional incorporation of ganglioside into intact cells: induction of choleragen responsiveness.
Proc Natl Acad Sci U S A. 1976 Apr;73(4):1034-7
PMID: 177969
-
Ultrastructural localization of cell membrane GM1 ganglioside by cholera toxin.
Proc Natl Acad Sci U S A. 1977 Sep;74(9):3782-6
PMID: 269432
-
Studies on the mechanism of membrane fusion. Role of head-group composition in calcium- and magnesium-induced fusion of mixed phospholipid vesicles.
Biochim Biophys Acta. 1981 Mar 20;642(1):182-95
PMID: 7225377
-
Interaction of Shigella shigae cytotoxin with receptors on sensitive and insensitive cells.
J Recept Res. 1980;1(2):199-213
PMID: 6895387
-
Hemolytic-uremic syndrome. Current concepts and management.
Pediatr Clin North Am. 1982 Aug;29(4):835-56
PMID: 7050864
-
Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.
Infect Immun. 1983 May;40(2):675-83
PMID: 6341244
-
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.
J Infect Dis. 1985 May;151(5):775-82
PMID: 3886804
-
Two distinct toxins active on Vero cells from Escherichia coli O157.
Lancet. 1985 Oct 19;2(8460):885-6
PMID: 2864594
-
Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.
Infect Immun. 1985 Dec;50(3):695-700
PMID: 3905611
-
Two-dimensional crystals of cholera toxin B-subunit-receptor complexes: projected structure at 17-A resolution.
Proc Natl Acad Sci U S A. 1986 Nov;83(22):8585-8
PMID: 3464971